Successful treatment of primary AL amyloidosis by VAD therapy, high-dose melphalan, and autologous peripheral stem cell transplantation

Clinical and Experimental Nephrology

Volumn 13, Issue 5, 2009, Pages 522-525

  Yamazaki, Osamu ^a   Ubara, Yoshifumi ^a   Suwabe, Tatsuya ^a   Nakanishi, Shohei ^a   Hoshino, Junichi ^a   Sawa, Naoki ^a   Hayami, Noriko ^a   Yamanouchi, Masayuki ^a   Takemoto, Fumi ^a   Kenmei, Takaichi ^a   Masuoka, Kazuhiro ^a   Oohashi, Kenichi ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

AL amyloidosis; Autologous peripheral blood stem cell transplantation; High dose melphalan; Proteinuria; SCT; VAD (vincristine, doxorubicin, and dexamethasone)

Indexed keywords

DEXAMETHASONE; DOXORUBICIN; MELPHALAN; PREDNISOLONE; VINCRISTINE;

ADULT; AMYLOIDOSIS; ANAMNESIS; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CASE REPORT; CLINICAL FEATURE; DRUG MEGADOSE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; MALE; THORAX RADIOGRAPHY;

AMYLOIDOSIS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEXAMETHASONE; DOXORUBICIN; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KIDNEY; MALE; MELPHALAN; MIDDLE AGED; VINCRISTINE;

EID: 70349659999     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-009-0198-y     Document Type: Article

References (9)

1. RA Kyle MA Gertz 1995 Primary systemic amyloidosis: clinical and laboratory features in 474 cases Semin Hematol 32 45 59 7878478 1:STN:280:DyaK2M7osVShsg%3D%3D
2. RA Kyle MA Gertz PF Greipp TE Witzig JA Lust MO Lacy TM Therneau 1997 A trial of three regimens of primary amyloidosis alone, melphalan, prednisolone, and melphalan, prednisone, and colchicine N Engl J Med 336 1202 1207 9110907 10.1056/NEJM199704243361702 1:CAS:528:DyaK2sXivFymurY%3D (Pubitemid 27183649)
3. RL Comenzo MA Gertz 2002 Autologous stem cell transplantation for primary systemic amyloidosis Blood 99 4276 4282 12036853 10.1182/blood.V99.12.4276 1:CAS:528:DC%2BD38XksFGlurc%3D (Pubitemid 34627192)
4. RL Comenzo E Vosburgh RH Falk, et al. 1998 Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients Blood 91 3662 3670 9573002 1:CAS:528:DyaK1cXjtFers7s%3D
5. A Jaccard P Moreau V Leblond X Leleu L Benboubker O Hermine C Recher B Asli B Lioure B Royer F Jardin F Bridoux B Grosbois J Jaubert JC Piette P Ronco F Quet M Cogne JP Fermand Myélome Autogreffe (MAG), Intergroupe Francophone du Myélome (IFM) Intergroup 2007 High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis N Engl J Med 357 11 1083 1093 17855669 10.1056/NEJMoa070484 1:CAS:528:DC%2BD2sXhtVGqt7rF (Pubitemid 47443213)
6. P Moreau V Leblond P Bourquelot T Facon A Huynh D Caillot O Hermine M Attal M Hamidou G Nedellec A Ferrant B Audhuy R Bataille N Milpied JL Harousseau 1998 Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients Br J Haematol 101 4 766 769 9674753 10.1046/j.1365-2141.1998.00772.x 1:CAS:528:DyaK1cXltVSgtLY%3D (Pubitemid 28308529)
7. AM Wardley GC Jayson DJ Goldsmith MC Venning P Ackrill JH Scarffe 1998 The treatment of nephrotic syndrome caused by primary (light chain) amyloid with vincristine, doxorubicin and dexamethasone Br J Cancer 78 6 774 776 9743299 1:CAS:528:DyaK1cXmsVKmsrw%3D
8. T Gono M Matsuda N Dohi K Hoshi T Tada K Sakashita K Koike M Aizawa S Ikeda 2003 Nephrotic syndrome due to primary AL amyloidosis, successfully treated with VAD and subsequent high-dose melphalan followed by autologous peripheral blood stem cell transplantation Intern Med 42 1 72 77 12583623 10.2169/internalmedicine.42.72
9. T Gono M Matsuda Y Shimojima W Ishii J Koyama K Sakashita K Koike Y Hoshii S Ikeda 2004 VAD with or without subsequent high-dose melphalan followed by autologous stem cell support in AL amyloidosis: Japanese experience and criteria for patient selection Amyloid 11 4 245 256 15678759 10.1080/13506120412331336907 (Pubitemid 40115923)